Deutsch English Français

Contact

EP3829537

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP3829537

EP3829537 - LOW DOSAGE INTRANASAL AMINOSTEROL DOSAGE FORMS AND METHODS OF USING THE SAME [Right-click to bookmark this link]
Status	Request for examination was made Status updated on 07.05.2021 Database last updated on 15.06.2024
Former	The international publication has been made Status updated on 08.02.2020
Most recent event Tooltip	25.08.2023	New entry: Renewal fee paid
Applicant(s)	For all designated states Enterin, Inc. 2005 Market Street, Suite 3125 Philadelphia, Pennsylvania 19103 / US
	[2021/23]
Inventor(s)	01 / ZASLOFF, Michael 2005 Market Street Suite 3125 Philadelphia, Pennsylvania 19103 / US
	02 / BARBUT, Denise 2005 Market Street Suite 3125 Philadelphia, Pennsylvania 19103 / US
	[2021/23]
Representative(s)	Altmann Stößel Dick Patentanwälte PartG mbB Theodor-Heuss-Anlage 2 68165 Mannheim / DE
	[N/P]
Former [2021/23]	Altmann Stößel Dick Patentanwälte PartG mbB Dudenstrasse 46 68167 Mannheim / DE
Application number, filing date	19845506.5	02.08.2019
	[2021/23]
	WO2019US44882
Priority number, date	US201862714470P	03.08.2018 Original published format: US 201862714470 P
	[2021/23]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2020028791
	Date:	06.02.2020
	Language:	EN
	[2020/06]
	Type:	A1 Application with search report
	No.:	EP3829537
	Date:	09.06.2021
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 06.02.2020 takes the place of the publication of the European patent application.
	[2021/23]
Search report(s)	International search report - published on:	KR	06.02.2020
	(Supplementary) European search report - dispatched on:	EP	19.08.2022
Classification	IPC:	A61K31/519, A61P1/10, A61P25/16, A61P25/28, A61K9/00, A61K9/08	[2022/25]
	CPC:	A61K9/0019 (EP); A61K31/575 (EP,US); A61K35/60 (EP); A61K45/06 (EP); A61K47/10 (US); A61K47/26 (US); (+) A61K9/0043 (EP,US); A61K9/0085 (EP); A61K9/08 (EP); A61P25/00 (EP); A61P29/00 (EP) (-)
	C-Set:	A61K31/575, A61K2300/00 (EP)
	Former IPC [2021/23]	A61K9/00, A61K31/575, A61K35/60, A61K45/06, A61P29/00, A61P25/00
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/23]
Extension states	BA	26.02.2021
	ME	26.02.2021
Title	German:	INTRANASALE DARREICHUNGSFORMEN VON AMINOSTEROL MIT NIEDRIGER DOSIERUNG UND VERFAHREN ZU DEREN VERWENDUNG	[2021/23]
	English:	LOW DOSAGE INTRANASAL AMINOSTEROL DOSAGE FORMS AND METHODS OF USING THE SAME	[2021/23]
	French:	FORMES POSOLOGIQUES D'AMINOSTÉROL INTRANASALE À FAIBLE DOSAGE ET PROCÉDÉS D'UTILISATION ASSOCIÉS	[2021/23]
Entry into regional phase	26.02.2021	National basic fee paid
	26.02.2021	Search fee paid
	26.02.2021	Designation fee(s) paid
	26.02.2021	Examination fee paid
Examination procedure	26.02.2021	Examination requested [2021/23]
	12.04.2023	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	20.06.2023	Amendment by applicant (claims and/or description)
Request for further processing for:	The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
	20.06.2023	Request for further processing filed
	20.06.2023	Full payment received (date of receipt of payment) Request granted
	28.06.2023	Decision despatched
	The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
	20.06.2023	Request for further processing filed
	20.06.2023	Full payment received (date of receipt of payment) Request granted
	28.06.2023	Decision despatched
Fees paid	Renewal fee
	13.08.2021	Renewal fee patent year 03
	15.06.2022	Renewal fee patent year 04
	24.08.2023	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]US5192756 (ZASLOFF MICHAEL [US], et al) [X] 1-10 * claim - *;
		[X]WO2006119211 (GENAERA CORP [US], et al) [X] 1-10 * claim - *;
		[X]WO2015200195 (ZASLOFF MICHAEL [US]) [X] 1-10 * claims 1-3,5-7,11-26 *;
		[E]WO2019241503 (ENTERIN INC [US]) [E] 1-10* claims 1,2,4 *;
		[X] - MICHELE PERNI ET AL, ACS CHEMICAL BIOLOGY, (20180628), vol. 13, no. 8, doi:10.1021/acschembio.8b00466, ISSN 1554-8929, pages 2308 - 2319, XP055662730 [X] 1-10 * page 2308, abstract * DOI: http://dx.doi.org/10.1021/acschembio.8b00466
		[X] - MICHELE PERNI ET AL, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20170117), vol. 114, no. 6, doi:10.1073/pnas.1610586114, ISSN 0027-8424, pages E1009 - E1017, XP055580296 [X] 1-10 * page E1009, abstract * DOI: http://dx.doi.org/10.1073/pnas.1610586114
		[X] - SHPAKOV A O, "Functional Activity of the Insulin Signaling System of the Brain in Health and Type 2 Diabetes Mellitus", NEUROSCIENCE AND BEHAVIORAL PHYSIOLOGY, CONSULTANTS BUREAU, NEW YORK, NY, US, vol. 47, no. 2, doi:10.1007/S11055-016-0385-8, ISSN 0097-0549, (20161217), pages 190 - 203, (20161217), XP036125244 [X] 1-10 * page 200, paragraph 2 * DOI: http://dx.doi.org/10.1007/s11055-016-0385-8
		[X] - MARCELO N. N. VIEIRA ET AL, "Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?", FRONTIERS IN AGING NEUROSCIENCE, (20170131), vol. 9, doi:10.3389/fnagi.2017.00007, XP055662734 [X] 1-10 * PTP1B inhibitors and conclusion; page 5, column 1 - column 2 * DOI: http://dx.doi.org/10.3389/fnagi.2017.00007
	International search	[X]US6143738 (ZASLOFF MICHAEL [US]) [X] 1-3 * See claims 1, 8, 10. *;
		[A]US2008058300 (MCLANE MICHAEL [US], et al) [A] 1-3 * See abstract; and claims 1, 35. *;
		[A]US2013217707 (FARAONE STEPHEN V [US]) [A] 1-3* See abstract; and claim 1. *;
		[A]US2018002370 (ZASLOFF MICHAEL [US]) [A] 1-3 * See abstract; and claims 1,2. *;
		[A]US2018133230 (ZASLOFF MICHAEL [US]) [A] 1-3 * See abstract; paragraph [0159]; and claims 1. *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p